CLINICAL TRIAL SUMMARY

MDACC Study No:2004-0051 (clinicaltrials.gov NCT No: NCT00095589)
Title:Detection of Bladder Cancer by Microsatellite Analysis (MSA) of Urinary Sediment
Principal Investigator:Ashish M. Kamat
Treatment Agent:None
Study Status:Terminated
Study Description:The goal of this clinical research study is to develop a new test to help
doctors detect bladder cancer in urine.

Hide details for General InformationGeneral Information

Disease Group:Bladder
Phase of Study:Phase I
Treatment Agents:None
Treatment Location:Independent Multicenter Arrangements
Estimated Length of Stay in Houston:Patient may stay overnight after Cytoscopy, but it is not required by study.
Supported By:N/A
Return Visit:Group 3 (Patients with Bladder Cancer) will have urine and blood samples and
cystoscopy with follow up Medical History every 3 months for 24 months.
Home Care:None


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Ashish M. Kamat
Dept:Urology
For Clinical Trial Enrollment:713-792-3250
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults